Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $168 million versus the consensus estimate of $167.67 million.

GUIDANCE:

Repligen sees FY2025 EPS of $1.67-$1.76, versus the consensus of $1.71. Repligen sees FY2025 revenue of $685-710 million, versus the consensus of $692.8 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.